FDA Drug recall D-0844-2022
alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1
- FDA Drug
- Class II
- terminated
- Published 2022-05-11
On 2022-05-11 the FDA classified a Class II recall of alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1 by Viatris, citing failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0844-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-04-28 |
| Published | 2022-05-11 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Viatris |
| Distribution | US |
Product
alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.
Reason
Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Identifiers
| ndc | 59762-0057-1 |
|---|---|
| ndc | 59762-0059-1 |
| ndc | 59762-0066-1 |
| ndc | 59762-0068-1 |
| code_info | Lot # EH8348, exp. date August 2023 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0844-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.